A blood biomarker test for brain amyloid impacts the clinical evaluation of cognitive impairment. - Monane M; Johnson KG; Snider BJ; Turner RS; Drake JD; Maraganore DM; Bicksel JL; Jacobs DH; Ortega JL; Henderson J; Jiang Y; Huang S; et al. (Annals of clinical and translational neurology, 2023)